丁基肼 | 3530-11-8

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 丁基肼
• 英文名称: butylhydrazine
• 英文别名: N-butylhydrazine
• CAS: 3530-11-8
• 化学式: C₄H₁₂N₂
• mdl: MFCD06655022
• 分子量: 88.1527
• InChiKey: XKLVLDXNZDIDKQ-UHFFFAOYSA-N

物化性质

• 沸点：
  141-142 °C(Press: 750 Torr)
• 密度：
  0.841 g/cm3
• 保留指数：
  822

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  6
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  38
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2928000090

反应信息

• 作为反应物：
  描述：

  丁基肼 在 亚硝酸乙酯 、 potassium ethoxide 作用下， 以 乙醚 、 乙醇 为溶剂， 反应 2.0h， 生成 (E)-potassium butanediazotate
  参考文献：
  名称：

  Mutagenicity of isomeric alkanediazotates, precursors for ultimate alkylating species of carcinogenic N-nitroso compounds

  摘要：

  Alkanediazohydroxides are common key intermediates in carcinogenesis and mutagenesis of N-nitroso compounds, which are widely found in human environment. Mutagenicity of (E)- and (Z)-potassium alkanediazotates, as precursors of corresponding alkanediazohydroxides were evaluated to investigate the effect of geometric isomerism and also the effect of alkyl groups on their biological activity. Mutagenicity of N-nitroso-N-alkylureas which spontaneously produce alkanediazohydroxides after non-enzymatic hydrolysis were also tested in comparison to that of the corresponding diazotates and other activated chemical species of N-nitrosamines. When the mutagenicity was assayed in three microbial strains, Salmonella typhimurium TA1535, and Escherichia coli WP2 and WP2 wrA, the order of mutagenic potency of the compounds with the same alkyl group was as follows; (E)-diazotates > (Z)-diazotates > nitrosoureas. The effect of alkyl groups on the mutagenic potency was different in Salmonella strain and in E. coli strains, and this result could be explained by the efficiency of O-6-alkylguanine-DNA alkyltransferase. In each bacterial strain, this effect of alkyl groups was similar in mutagenicity induced by (E)- and (Z)-diazotates, N-nitroso-N-alkylureas and other activated N-nitrosodialkylamines such as alpha-hydroxy nitrosamines. The geometrical isomerism affected the mutagenicity of (E)- and (Z)-potassium alkanediazotates, and the result suggested that alkanediazohydroxides react through diazonium ions in a cage rather than through free alkyldiazonium ions which have no geometrical isomerism. Our results confirmed that (E)-potassium alkanediazotates, (Z)-potassium alkanediazotates and N-nitroso-N-alkylureas all decomposed through diazohydroxides, and that alkanediazohydroxides are the active alkylating species of N-nitroso compounds, and also that the geometrical isomerism is important for carcinogenic N-nitroso compounds to show their biological activity. (C) 1998 Elsevier Science B.V.

  DOI：

  10.1016/s1383-5718(97)00180-0
• 作为产物：
  描述：

  1-Butyl-1-diphenylphosphorylhydrazine 在 盐酸 作用下， 生成 丁基肼
  参考文献：
  名称：

  Solid NaOH/K2CO3 - A new highly effective base for phase-transfer catalysed N-alkylation of diphenylphosphinic hydrazide

  摘要：

  DOI：

  10.1016/s0040-4039(01)85717-8
• 作为试剂：
  描述：

  丁基肼 、 在 丁基肼 作用下， 生成 ethyl (E)-3-[1-butyl-5-(2-hydroxy-4-methoxyphenyl)pyrazol-4-yl]-2-[(6-methoxy-1,3-benzodioxol-5-yl)methyl]prop-2-enoate
  参考文献：
  名称：

  Endothelin receptor antagonists

  摘要：

  这是申请书编号为08/718,562的延续申请，申请日期为1996年9月30日，该申请是国际申请号为PCT/US96/12581的371项申请，该国际申请于1996年8月2日提交；该申请同时要求以下临时申请的优先权：60/001,792，申请日期为1995年8月2日；以及60/010,982，申请日期为1996年2月1日。

  公开号：

  US05969151A1

文献信息

• Synthesis of 4-Substituted Chlorophthalazines, Dihydrobenzoazepinediones, 2-Pyrazolylbenzoic Acid, and 2-Pyrazolylbenzohydrazide via 3-Substituted 3-Hydroxyisoindolin-1-ones
  作者：Hanh Nho Nguyen、Victor J. Cee、Holly L. Deak、Bingfan Du、Kathleen Panter Faber、Hakan Gunaydin、Brian L. Hodous、Steven L. Hollis、Paul H. Krolikowski、Philip R. Olivieri、Vinod F. Patel、Karina Romero、Laurie B. Schenkel、Stephanie D. Geuns-Meyer

  DOI：10.1021/jo3000628

  日期：2012.4.20

  hydrazine, followed by chlorination with POCl3. We have also discovered two novel transformations of 3-vinyl- and 3-alkynyl-3-hydroxyisoindolinones. Addition of vinyl organometallic reagents to N,N-dimethylaminophthalimide (8a) provided dihydrobenzoazepinediones 15a–15c via the proposed ring expansion of 3-vinyl-3-hydroxyisoindolinone intermediates. 3-Alkynyl-3-hydroxyisoindolinones react with hydrazine and

  在本文中，我们描述了以良好的总收率进行的4-取代的氯邻苯二甲腈的一般三步合成。在关键步骤中，N，N-二甲基氨基邻苯二甲酰亚胺（8a）指导烷基，芳基和杂芳基有机金属试剂的选择性单加成反应，得到3-取代的3-羟基异吲哚满酮9b，9i - 9am。通过与肼反应，然后用POCl 3氯化，许多羟基异吲哚啉酮可转化为氯酞嗪1b - 1v。我们还发现了3-乙烯基和3-炔基-3-羟基异吲哚满酮的两个新颖的转化。将乙烯基有机金属试剂添加到N，N-二甲基氨基邻苯二甲酰亚胺（8a）通过提议的3-乙烯基-3-羟基异吲哚满酮中间体的扩环作用提供了二氢苯并氮杂氮杂二酮15a - 15c。3-炔基-3-羟基异吲哚啉酮与肼和取代的肼反应，生成2-吡唑基苯甲酸16a - 16d和2-吡唑基苯并酰肼17a - 17g，而不是预期的炔基酞菁。
• Synthesis and Antihypertensive Activity of 4-(Diazabicyclo[4.1.0]-heptenyloxy)benzopyran Derivatives and Their Analogues.
  作者：Haruhiko HORINO、Tetsuya MIMURA、Katsuji KAGECHIKA、Masahiro OHTA、Hideo KUBO、Masayuki KITAGAWA

  DOI：10.1248/cpb.46.602

  日期：——

  0]hept- 2-en-2-yl)oxy]-2H-1-benzopyrans and their analogues were synthesized and evaluated on potassium channel opening and hypotensive activities. Compound (-)-13B with a (4-methyl-5-oxo-3,4-diazabicyclo[4.1.0]hept-2-en-2-yl)oxy group for the 4-position of the benzopyran ring was 3 times as potent as EMD 57283 (II), the lead compound, in hypotensive activity. The results would demonstrate that 5-oxo-3,4-diazabicyclo[4

  一系列的3,4-二氢-3-羟基-4-[（5-氧代-3,4-二氮杂双环[4.1.0]庚二-2-烯-2-基）氧基] -2H-1-苯并吡喃和合成了它们的类似物，并对钾通道的开放和降压活性进行了评估。对于苯并吡喃环的4-位具有（4-甲基-5-氧代-3,4-二氮杂双环[4.1.0]庚-2-烯-2-基）氧基的化合物（-）-13B为3在降压活动中的功效是主要化合物EMD 57283（II）的两倍。结果表明5-氧代-3，4-二氮杂双环[4.1.0]庚-2-烯-2-基氧基部分作为苯并吡喃型钾通道开放剂的4-位上的取代基是有效的。
• An efficient one-pot synthesis of carbazates and dithiocarbazates through the corresponding alcohols using Mitsunobu’s reagent
  作者：A. K. Chaturvedi、D. Chaturvedi、N. Mishra、V. Mishra

  DOI：10.1007/bf03249073

  日期：2011.6

  A novel Mitsunobu-based protocol has been developed for the synthesis of carbazates and dithiocarbazates through the variety of corresponding primary, secondary and tertiary alcohols and various kinds of substituted hydrazines using Mitsunobu’s reagent and CO2/CS2 system, in good to excellent yields.

  使用Mitsunobu的试剂和CO 2 / CS 2系统，已开发出一种新颖的基于Mitsunobu的新方案，可通过使用Mitsunobu的试剂和CO 2 / CS 2系统通过各种相应的伯醇，仲醇和叔醇以及各种取代的肼来合成氨基甲酸酯和二硫代氨基甲酸酯。
• [EN] IMMUNOCONJUGATES TARGETING PD-L1<br/>[FR] IMMUNOCONJUGUÉS CIBLANT LE PD-L1
  申请人：BOLT BIOTHERAPEUTICS INC

  公开号：WO2020190734A1

  公开（公告）日：2020-09-24

  The invention provides an immunoconjugate of formula (I) or (II). Antibody-adjuvant immunoconjugates of the invention, comprising an antibody construct that has an antigen binding domain that binds programmed death-ligand 1 (PD-L1) linked to one or more adjuvants, demonstrate superior pharmacological properties over conventional antibody conjugates. The invention further provides compositions comprising and methods of treating cancer with the immunoconjugate.

  该发明提供了公式（I）或（II）的免疫结合物。该发明的抗体-佐剂免疫结合物包括一个抗体构造，其具有结合程序性死亡配体1（PD-L1）的抗原结合结构域，与一个或多个佐剂连接，表现出比传统抗体结合物更优越的药理特性。该发明还提供了包含该免疫结合物的组合物和治疗癌症的方法。
• METHOD FOR PRODUCING POLYMERIZABLE COMPOUND
  申请人：DIC Corporation

  公开号：US20180354922A1

  公开（公告）日：2018-12-13

  The polymerizable compound has a hydrazone moiety. The present invention also provides a polymerizable composition in which discoloration and reduction of aligning property do not easily occur. Furthermore, the present invention provides a polymer obtained by polymerizing a polymerizable composition containing a compound obtained by the production method and an optically anisotropic body using the polymer. The present invention provides a method for producing a polymerizable compound including a step of reacting a compound represented by General Formula (I-B-a) with a compound represented by General Formula (I-B-b) to obtain a compound represented by General Formula (I-C), and provides a composition which contains a compound obtained by this production method.

  这种可聚合化合物具有醛肟基团。本发明还提供了一种可聚合组合物，其中不容易发生变色和对齐性能降低。此外，本发明提供了一种通过聚合含有通过生产方法获得的化合物的可聚合组合物以及使用聚合物制备光学各向异性体的聚合物。本发明提供了一种生产可聚合化合物的方法，包括将通式（I-B-a）表示的化合物与通式（I-B-b）表示的化合物反应以获得通式（I-C）表示的化合物的步骤，并提供了包含通过这种生产方法获得的化合物的组合物。

表征谱图